November 10, 2003
Hayashibara Biochemical Laboratories, Inc of Okayama, Okayama Prefecture, recently announced that it has developed a basic design for a peptide antigen that shows excellent effects by transmucosal administration without the use of adjuvants, or substances that boost induction of antibodies...read more